In an attempt to identify germline mutations in additional high risk breast cancer susceptibility genes, we have optimised and applied the GINI method on lymphoblastoid cell lines derived from the blood of women from multiple-case non- BRCA1/2 breast cancer families. This evidence concerns the gene BRCA1 and breast cancer.